Refractory Cholangiocarcinoma
2 clinical trials · Condition
◉ Watch Refractory Cholangiocarcinoma
| Record | Firm | Date |
|---|---|---|
| NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma (NCT06420349) | Mayo Clinic | 2024-05-31 |
| Testing Olaparib and AZD6738 in IDH1 and IDH2 Mutant Tumors (NCT03878095) | National Cancer Institute (NCI) | 2020-01-30 |
Track Refractory Cholangiocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.